CountriesSwitzerland

Products 1 to 10 of 19

Antibiotic - EV-035 by Emergent Biosolutions, Inc.
Biotech components: Bacteria
Business models: B2C
Country of production: USA
Country of distribution: USA + Switzerland
Intended consumer: Government
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 86,000,000 CHF
Funding types: Shareholder Investment
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: EVE (SWX)
Value chain stage: Finished Product
BIO-SA Based Resins & Coatings by BioAmber, Inc.
Biotech components: Plant
Business models: B2C
Country of production: Canada
Country of distribution: Benelux + France + Iberia + Germany + Poland + Switzerland + UK + Ireland
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/08 14:30 (6 years ago)
Known funding amount: 155,600,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: BIOA (NYSE)
Value chain stage: Finished Product
Biotech components: Gene Editing
Business models: B2C
Country of production: Switzerland
Country of distribution: Switzerland
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/08 14:47 (6 years ago)
Known funding amount: N/A
Funding types: Government
Industry: Health
Market status: Early Stage Concept
Organization type(s): Research Institution + University
Product categories: Medical Treatment
Production process: Closed Production
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Clearwood (TM) Patchouli Oil by Amyris + Firmenich
Biotech components: Plant
Business models: B2C
Country of production: USA + Switzerland
Country of distribution: Switzerland
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2019/02/15 12:43 (6 years ago)
Known funding amount: 471,900,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: Personal Care (Topical)
Production process: Closed Production
Source: SynBio Database
Trading symbol: AMRS (NASDAQ)
Value chain stage: Finished Product
CRISPR-Cas9 by CRISPR
Biotech components: Molecule
Business models: B2B
Country of production: Switzerland
Country of distribution: N/A
Intended consumer: Research
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/08 13:59 (6 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Science
Market status: On the market
Organization type(s): Public Company
Product categories: Research
Production process: Closed Production
Source: Web search
Trading symbol: CRSP (NASDAQ)
Value chain stage: Finished Product
Biotech components: Molecule
Business models: B2B
Country of production: Switzerland
Country of distribution: USA + Canada + Switzerland
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2019/05/15 15:47 (5 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: Open Release
Source: Web search
Trading symbol: BAS (ETR)
Value chain stage: Input
Detalzym GA L-E5 Glucoamylase by BASF + Verenium
Biotech components: Enzyme
Business models: B2B
Country of production: Switzerland
Country of distribution: Germany + USA + China + Japan
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/12/26 15:16 (6 years ago)
Known funding amount: 2,147,483,647 EUR
Funding types: Shareholder Investment
Industry: Industrial
Market status: No longer on the market
Organization type(s): Public Company
Product categories: Fuel and Energy
Production process: Closed Production
Source: SynBio Database
Trading symbol: BAS (ETR)
Value chain stage: Input
Eradicake Alpha-Amylase by BASF + Verenium
Biotech components: Enzyme
Business models: B2B
Country of production: Switzerland
Country of distribution: USA + Mexico + Canada + Germany + Singapore + Brazil + China
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/12/26 15:23 (6 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: BAS (ETR)
Value chain stage: Input
EveNootkatone by Evolva
Biotech components: Plant
Business models: B2B
Country of production: Switzerland
Country of distribution: USA + Europe
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 86,000,000 CHF
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Public Company
Product categories: Additive
Production process: Closed Production
Source: SynBio Database
Trading symbol: EVE (SWX)
Value chain stage: Input
EverSweetâ„¢ by Evolva + Cargill
Biotech components: Plant
Business models: B2B + B2C
Country of production: Switzerland
Country of distribution: USA + Europe
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/09/13 15:54 (6 years ago)
Known funding amount: 86,000,000 CHF
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Private Company
Product categories: Chemical
Production process: Closed Production
Source: NASEM Database
Trading symbol: EVE (SWX)
Value chain stage: Input